Form 4: Teladoc Health Executive Waters Sells Shares to Cover Tax Obligations

Sentiment:

SEC Form 4


Teladoc Health's Chief Operating Officer, Michael Willem Waters, reports the sale of shares to cover tax obligations related to vesting performance stock units and restricted stock units.

Summary

  • Michael Willem Waters, the Chief Operating Officer of Teladoc Health, Inc. [TDOC], reported changes in beneficial ownership.
  • On August 30, 2024, Waters converted 2,113 performance stock units and 6,200 restricted stock units into common stock.
  • On September 3, 2024, Waters sold 4,218 shares of common stock at a price of $7.164 per share.
  • The sales were to cover tax withholding obligations related to the vesting of performance stock units and restricted stock unit awards.
  • Following these transactions, Waters directly owns 78,309 shares of Teladoc Health common stock.
  • Waters also holds 12,679 performance stock units and 37,204 restricted stock units.

Sentiment

Score: 5

Explanation: The document is a standard SEC Form 4 filing, indicating routine stock transactions by an executive. It doesn't inherently convey positive or negative sentiment about the company's performance.

Industry Context

Executive stock transactions are a common occurrence in publicly traded companies. They can be driven by various factors, including tax obligations, diversification, or personal financial planning. It's important to consider the context of these transactions and whether they align with the company's overall performance and outlook.

Comparison to Industry Standards

  • Executive compensation packages often include stock options, restricted stock units, and performance-based equity awards.
  • Sales of shares to cover tax obligations upon vesting are a standard practice among executives in publicly traded companies.
  • Comparing the size and frequency of executive stock transactions at Teladoc Health to those of its peers (e.g., Amwell, Livongo (prior to its acquisition by Teladoc), and similar telehealth companies) can provide insights into the company's compensation practices and executive sentiment.

Stakeholder Impact

  • The sale of shares by an executive could have a minor impact on shareholder sentiment, but is unlikely to have a significant impact on the company's operations or financial performance.
  • Employees may be interested in executive stock transactions as an indicator of company performance and executive confidence.

Key Dates

DateDescription
03/03/2023Reporting person was granted 74,405 restricted stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter.
03/01/2024One-third of performance stock units and restricted stock units vest.
08/30/2024Conversion of 2,113 performance stock units and 6,200 restricted stock units to common stock.
09/03/2024Sale of 4,218 shares of common stock at $7.164 per share.
09/04/2024Date of signature for the Form 4 filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.